Spots Global Cancer Trial Database for palonosetron
Every month we try and update this database with for palonosetron cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer | NCT03040726 | Malignant Neopl... Nausea Vomiting | Netupitant Palonosetron Palonosetron Hy... Placebo Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | NCT00412425 | Melanoma | Palonosetron | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy | NCT01018758 | Chemotherapy-In... Non Hodgkin's L... | Palonosetron | 18 Years - | Gruppo Italiano Studio Linfomi | |
| Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy | NCT03674294 | Gastrointestina... Chemotherapy-in... | Aprepitant Palonosetron Dexamethasone Placebo Oral Ta... | 18 Years - 50 Years | Sun Yat-sen University | |
| MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy | NCT02135510 | Solid Tumors | metoclopramide dexamethason palonosetron | 18 Years - | Amsterdam UMC, location VUmc | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone | NCT02532634 | Cancer Tumors | ramosetron, apr... palonosetron, a... | 19 Years - | Kangdong Sacred Heart Hospital | |
| Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer | NCT05841849 | Breast Cancer Chemotherapy-in... | Aprepitant Palonosetron Fosaprepitant | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy | NCT01046240 | Emesis | Palonosetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer | NCT00553059 | Chemotherapy-in... Unspecified Adu... | dexamethasone dronabinol palonosetron hy... placebo | 18 Years - | M.D. Anderson Cancer Center | |
| The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy | NCT01909856 | Cancer | Palonosetron Granisetron Dexamethasone Cisplatin | 18 Years - 90 Years | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy | NCT01046240 | Emesis | Palonosetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting | NCT01339260 | Chemotherapy-In... | Netupitant and ... Palonosetron Dexamethasone | 18 Years - | Helsinn Healthcare SA | |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | NCT00412425 | Melanoma | Palonosetron | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting | NCT01031498 | Acute Myelogeno... Chemotherapy-in... | Ondansetron Palonosetron | 18 Years - | M.D. Anderson Cancer Center | |
| An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients | NCT00666783 | Chemotherapy-In... | palonosetron Granisetron | 18 Years - 70 Years | Xijing Hospital | |
| Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. | NCT03606369 | Breast Neoplasm Antineoplastic ... Antiemetics Quality of Life | Palonosetron Ondansetron | 18 Years - | Instituto Nacional de Cancerologia de Mexico | |
| MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy | NCT02135510 | Solid Tumors | metoclopramide dexamethason palonosetron | 18 Years - | Amsterdam UMC, location VUmc | |
| Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer | NCT05841849 | Breast Cancer Chemotherapy-in... | Aprepitant Palonosetron Fosaprepitant | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) | NCT00410488 | Sarcoma Nausea Vomiting | Palonosetron - ... Palonosetron - ... Adriamycin Ifosfamide chem... Zinecard Mesna Vincristine Dexamethasone | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | NCT00412425 | Melanoma | Palonosetron | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting | NCT03204279 | Chemotherapy-in... | Netupitant Palonosetron Netupitant Palonosetron | - 17 Years | Helsinn Healthcare SA | |
| Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy | NCT03960151 | Germ Cell Tumor | Rolapitant Palonosetron Olanzapine Dexamethasone | 18 Years - | Hoosier Cancer Research Network | |
| Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy | NCT01018758 | Chemotherapy-In... Non Hodgkin's L... | Palonosetron | 18 Years - | Gruppo Italiano Studio Linfomi | |
| Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide | NCT00900757 | Malignant Gliom... | Palonosetron (P... | 18 Years - 90 Years | Duke University | |
| Multi-day Doses in Prevention of Nausea and Emesis | NCT00600353 | Myeloma, Plasma... Lymphoma, Malig... | Palonosetron Aprepitant Dexamethasone | 18 Years - | University of Kansas Medical Center | |
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy | NCT01046240 | Emesis | Palonosetron | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation | NCT04308837 | Gastric Cancer Stomach Cancer | Paclitaxel Carboplatin Dexamethasone Diphenhydramine Famotidine Palonosetron 3D conformal or... Surgical resect... Adjuvant Chemot... | 18 Years - | Icahn School of Medicine at Mount Sinai |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
